NCT06000657 - Efficacy and Safety of Switching to Vemliver From Entecavir in Chronic Hepatitis B Patients Previously Treated With Entecavir | Biotech Hunter

Enrollment

196

Participants

Timeline

Start Date

August 28, 2023

Primary Completion Date

February 3, 2025

Study Completion Date

February 3, 2025

Conditions

Hepatitis B, Chronic

Interventions

DRUG

Vemliver tablet

Chronic Hepatitis B Patients Who Pretreated with Entecavir switching to Vemliver tab (Tenofovir Alafenamide Hemitartrate)

DRUG

Baracross Tablet

Chronic Hepatitis B Patients Who Pretreated with Entecavir continuting treatement with Baracross Tablet

Trial Locations (1)

Seoul National University Hospital, Seoul